CClinicalTrials.gg
WithdrawnNCT05098834Updated Sep 19, 2024

Electrical Impedence Tomography With ENLIGHT2100

An interventional study of ENLIGHT 2100 ventilatory electrical impedance tomograph in Extubation, sponsored by Duke University. Withdrawn at 1 site in United States. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Duke University · Not applicable, Interventional, and Diagnostic

Why this study was withdrawn
Device received FDA approval
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
Up to 17 Years
Sex
All
01

Study summary

Children with acute respiratory failure often need a breathing tube attached to a breathing machine, called a mechanical ventilator, to assist their breathing until they can recover. Once the cause of respiratory failure has resolved or improved enough, the breathing tube can be removed, and that is called extubation. The Extubation Readiness Test (ERT) is a simple evaluation commonly performed in the intensive care unit to determine if a child is ready to have the breathing tube removed.

The purpose of this study is to better understand how the ERT and the eventual removal of the breathing tube affect where the air is in the lungs, and whether this can help predict which children will succeed or fail having the breathing tube taken out. This can done be at the bedside with a device called electrical impedance tomograph. This novel device is painless and uses a belt fitted with sensors placed around the chest to show where the air is in the lungs.

02

Conditions studied

  • Extubation

Keywords

  • Acute respiratory failure
  • Breathing tube
  • Mechanical ventilator
03

In context

Lead sponsor

Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.

Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients less than 17 years of age admitted to the Duke Children's PICU or PCICU with acute respiratory failure due to a pulmonary illness will be considered eligible for the study

Exclusion criteria

Exclusion Criteria:

  • Patients with corrected gestational age less than 37 weeks
  • Patients with contraindications to the ENLIGHT device (i.e. temporary or permanent pacemaker, vagal nerve stimulator, automatic implanted defibrillator, chest tubes that interfere with electrode belt placement, open chest wounds, unstable thorax, severe chest wall deformities)
  • known pregnancy
  • Patients previously enrolled in this study will be excluded from participation.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    PICU and PCICU Patients

    Patients younger than 17 years of age receiving mechanical ventilation for an acute respiratory illness will be approached to participate prior to initiation of an ERT for clinical purposes.

    Device: ENLIGHT 2100 ventilatory electrical impedance tomograph

Interventions

  • DeviceENLIGHT 2100 ventilatory electrical impedance tomograph

    The ENLIGHT 2100 system will remain connected to the patient for data acquisition from immediately prior to initiation of the ERT until up to 24 hours following extubation.

06

What researchers measure

Primary outcomes

  1. Change in expiratory lung volume as measured by global lung electrical impedance

    Time frame: Baseline, 60 mins, 75 mins, 90 mins

Secondary outcomes

  1. Change in regional ventilation (Anterior/Posterior) distribution as measured by regional electrical impedance

    Time frame: Baseline, 60 mins, 75 mins, 90 mins

  2. Change in regional ventilation (Right/Left) distribution as measured by regional electrical impedance

    Time frame: Baseline, 60 mins, 75 mins, 90 mins

  3. Percent of failed extubation as measured by need for re-intubation

    Time frame: Within 24 hours

07

Study locations

1 site
  • Duke University
    Durham, North Carolina 27705, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05098834
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Oct 28, 2021
Start date
Aug 2024 (estimated)
Primary completion
Jan 2025 (estimated)
Completion
Jan 2025 (estimated)
Last update
Sep 19, 2024

Study contacts

Alexandre Rotta, MD, FCCM
principal investigator · Duke University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion